Recurrent Implantation Failure Clinical Trial
Official title:
The PIP Study- Pre- IVF Immune Profiling Study
Many IVF clinics offer testing for immune cells in the blood and endometrium as it has been suggested that abnormal levels of these cells can affect fertility or the chance of an IVF cycle working. However, routinely offering these tests remains highly controversial as the scientific evidence behind the tests is not of a high quality. The PIP Study aims to find out how a woman's blood and endometrial immune cells affect the likelihood of an IVF cycle working and whether or not they are different in women with subfertility and implantation failure. This feasibility study aims to find out if it is possible to enrol enough women into the research study. If this is successful, the investigators will then go on to recruit a larger group of women into the main PIP study to enable them to investigate the impact of immune profiling on IVF success in more detail.
Although there are examples of autoimmune associated pregnancy pathology, notably the
anti-phospholipid syndrome (1), robust evidence of immune mediated pregnancy failure is
limited. However for many years there have been persistent reports of a possible association
between 'abnormal' levels of peripheral or endometrial immune cell populations (predominantly
NK cells), altered cell function or cytokine production (by NK and T cells) and subfertility,
recurrent failed implantation or recurrent miscarriage (2-5). Many fertility clinics offer
testing for a variety of peripheral blood immune cell parameters (NK cell numbers,
cytotoxicity assays, Tregs, cytokine assays, etc) or endometrial parameters (most commonly NK
cell numbers). Furthermore, treatments including corticosteroids, immunoglobulin,
intralipids, biologic agents (e.g.: anti-TNFα therapy) are commonly offered to treat
'abnormal' results. The testing and treatment of immune mediated subfertility and
implantation failure remains highly controversial for a number of reasons:
1. To date there is little evidence that blood or endometrial immune cell numbers,
activation status or function, are associated with either implantation failure or
successful IVF treatment (6).
2. There is little evidence in the literature as to normal parameters of endometrial or
blood immune cell populations in fertile women. Of note, a recent meta-analysis (6) of
blood NK cells describes a total of 106 fertile controls and compares them to 249 women
who were either subfertile or had recurrent implantation failure. This is the largest
dataset of controls however the 6 included studies vary in how the cells were measured
and therefore pooling these data is of limited value. Studies assessing endometrial NK
cells comprised only 20 fertile women and 40 subfertile women.
3. The majority of studies compare a pathology (e.g.: Recurrent Implantation Failure (RIF))
with controls but do not have outcome data of the subsequent IVF cycles.
4. It is often argued that blood testing can be of no value as the immune cell populations
in the endometrium are phenotypically and functionally different to those in the
periphery (7). However the majority of clinical testing is done in blood. There are only
a few small studies that compare endometrial and blood parameters in the same patients
with no evidence to date that blood NK cells reflect the endometrial NK population.
The evidence above describes the limited data on which routine clinical testing is performed.
Added to which, there are no high quality Randomised Controlled Trials showing evidence of
benefit for the treatments that are used. In this study the investigators propose to describe
in detail normal endometrial and blood immune cell parameters as this has not previously been
done in a large population In order to achieve this, women who are undergoing a first cycle
or second cycle of IVF for male factor subfertility requiring Intracytoplasmic Sperm
injection (ICSI) will be recruited. Those women who go on to have a live birth will be
considered to be fertile controls (as their reason for IVF was a male factor and pregnancy
was achieved at the first attempt). A sub-group of such participants will be used to describe
the normal population (with standard deviations) and to use as a control group to compare to
pathologies (RIF and subfertility).
The investigators wish to recruit broadly to the study-250 women overall but they have not
defined a recruitment target for each group so that they can, at the end of the feasibility
study identify the proportions of the 250 women who fall into each subgroup. Depending on the
findings the investigators may need to target specific groups in the main study.
The purpose of the feasibility study is to determine the recruitment rate in the screened
population for a larger fully powered study. The investigators will recruit all women under
the age of 40 (at time of egg collection) from IVI clinics in the UK and the Wolfson
Fertility Centre who are eligible and wish to recruit to the study. Within this population of
recruits there will be three specific groups:
1. Women in a first or second cycle of IVF for male factor subfertility requiring ICSI.
2. Women with a history of RIF (using the definition described in (8))
3. Any women with a history of at least 1 year of subfertility.
Inclusion in the study will require women to undertake a single visit to have a blood sample
and an endometrial biopsy during the mid-luteal phase of the cycle before IVF treatment.
There are minimal risks (besides the small risk of bruising and discomfort) from blood tests.
Endometrial biopsy (known clinically as an endometrial 'scratch') is a procedure that is
commonly undertaken prior to IVF treatment, as there is evidence that a scratch increases the
pregnancy rate in the subsequent IVF cycle (9). Endometrial biopsy causes some discomfort at
the time of the procedure but has no significant risks to participants.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04528277 -
Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis
|
Phase 3 | |
Recruiting |
NCT04998279 -
Intrauterine Infusion of GCSF and Reproductive Outcomes in Infertile Women With History of RIF
|
||
Completed |
NCT03267797 -
hCG-activated PBMC-therapy in RIF Patients
|
N/A | |
Recruiting |
NCT04118959 -
Role of Atosiban in Recurrent Implantation Failure
|
||
Recruiting |
NCT05343572 -
Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
|
Early Phase 1 | |
Not yet recruiting |
NCT02752568 -
Assisted Hatching Versus Endometrial Scratch in Recurrent Implantation Failure
|
N/A | |
Recruiting |
NCT04822207 -
Effect of Acupuncture on the Clinical Outcome of IVF-ET in Patients With Recurrent Implantation Failure
|
N/A | |
Recruiting |
NCT03900780 -
Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure
|
N/A | |
Not yet recruiting |
NCT03549728 -
Effect of Granulocyte Colony-stimulating Factor on Clinical Pregnancy Rate in Patients With Endometriosis
|
Phase 2 | |
Completed |
NCT03174964 -
Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure
|
Phase 2 | |
Completed |
NCT03161340 -
Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure
|
Phase 2 | |
Not yet recruiting |
NCT01278706 -
Endometrial Biopsy Protocol for In Vitro Fertilization (IVF)
|
N/A | |
Completed |
NCT00750451 -
Low Molecular Weight Heparin in Recurrent Implantation Failure
|
N/A | |
Not yet recruiting |
NCT03690830 -
Use of Metabolomics for the Identification of Endometrial Biomarkers for IRPL and RIF After in Vitro Fertilization
|
N/A | |
Not yet recruiting |
NCT03355937 -
Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure
|
N/A | |
Recruiting |
NCT05169541 -
Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction
|
||
Completed |
NCT04085783 -
PRP in Recurrent Implantation Failure
|
N/A | |
Not yet recruiting |
NCT03365466 -
Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women
|
N/A | |
Active, not recruiting |
NCT03421639 -
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
|
Phase 4 | |
Recruiting |
NCT04293068 -
Effect of Reproductive Tract Microbiota on Pregnancy Outcome in IVF/ICSI
|